These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 20302819

  • 1. Differential function of phosphodiesterase families in the brain: gaining insights through the use of genetically modified animals.
    Kelly MP, Brandon NJ.
    Prog Brain Res; 2009; 179():67-73. PubMed ID: 20302819
    [Abstract] [Full Text] [Related]

  • 2. Overview of PDEs and their regulation.
    Omori K, Kotera J.
    Circ Res; 2007 Feb 16; 100(3):309-27. PubMed ID: 17307970
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling.
    Conti M, Beavo J.
    Annu Rev Biochem; 2007 Feb 16; 76():481-511. PubMed ID: 17376027
    [Abstract] [Full Text] [Related]

  • 5. Phosphodiesterases in the central nervous system.
    Kleppisch T.
    Handb Exp Pharmacol; 2009 Feb 16; (191):71-92. PubMed ID: 19089326
    [Abstract] [Full Text] [Related]

  • 6. Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases.
    Fischmeister R, Castro LR, Abi-Gerges A, Rochais F, Jurevicius J, Leroy J, Vandecasteele G.
    Circ Res; 2006 Oct 13; 99(8):816-28. PubMed ID: 17038651
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC, Shih CM, Lai YH, Chen JH, Huang HL.
    Biochem Pharmacol; 2004 Nov 15; 68(10):2087-94. PubMed ID: 15476679
    [Abstract] [Full Text] [Related]

  • 8. Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6.
    White JB, Thompson WJ, Pittler SJ.
    Mol Vis; 2004 Oct 06; 10():738-49. PubMed ID: 15480303
    [Abstract] [Full Text] [Related]

  • 9. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
    Cheng J, Grande JP.
    Exp Biol Med (Maywood); 2007 Jan 06; 232(1):38-51. PubMed ID: 17202584
    [Abstract] [Full Text] [Related]

  • 10. Mammalian sperm phosphodiesterases and their involvement in receptor-mediated cell signaling important for capacitation.
    Baxendale RW, Fraser LR.
    Mol Reprod Dev; 2005 Aug 06; 71(4):495-508. PubMed ID: 15856425
    [Abstract] [Full Text] [Related]

  • 11. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):110-7. PubMed ID: 16458289
    [Abstract] [Full Text] [Related]

  • 12. Assays for cyclic nucleotide-specific phosphodiesterases (PDEs) in the central nervous system (PDE1, PDE2, PDE4, and PDE10).
    Deng C, Wang D, Bugaj-Gaweda B, De Vivo M.
    Curr Protoc Neurosci; 2007 Jan 08; Chapter 7():Unit 7.21. PubMed ID: 18428663
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An update view on the substrate recognition mechanism of phosphodiesterases: a computational study of PDE10 and PDE4 bound with cyclic nucleotides.
    Lau JK, Cheng YK.
    Biopolymers; 2012 Nov 08; 97(11):910-22. PubMed ID: 22899366
    [Abstract] [Full Text] [Related]

  • 15. Behavioral characterization of mice deficient in the phosphodiesterase-10A (PDE10A) enzyme on a C57/Bl6N congenic background.
    Siuciak JA, McCarthy SA, Chapin DS, Martin AN, Harms JF, Schmidt CJ.
    Neuropharmacology; 2008 Feb 08; 54(2):417-27. PubMed ID: 18061215
    [Abstract] [Full Text] [Related]

  • 16. Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study.
    Oelke M, Hedlund P, Albrecht K, Ellinghaus P, Stief CG, Jonas U, Andersson KE, Uckert S.
    Urology; 2006 May 08; 67(5):1111-6. PubMed ID: 16635522
    [Abstract] [Full Text] [Related]

  • 17. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
    Ahlström M, Pekkinen M, Huttunen M, Lamberg-Allardt C.
    Cell Mol Biol Lett; 2005 May 08; 10(2):305-19. PubMed ID: 16010295
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system.
    Zhu Y, Yao J, Meng Y, Kasai A, Hiramatsu N, Hayakawa K, Miida T, Takeda M, Okada M, Kitamura M.
    Br J Pharmacol; 2006 Jul 08; 148(6):833-44. PubMed ID: 16751794
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis.
    Netherton SJ, Maurice DH.
    Mol Pharmacol; 2005 Jan 08; 67(1):263-72. PubMed ID: 15475573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.